Hla-Drb1*11 And Variants Of The Mhc Class Ii Locus Are Strong Risk Factors For Systemic Juvenile Idiopathic Arthritis
Tarih
2015Yazar
Ombrello, Michael J.
Remmers, Elaine F.
Tachmazidou, Ioanna
Grom, Alexei
Foell, Dirk
Haas, Johannes-Peter
Martini, Alberto
Gattorno, Marco
Ozen, Seza
Prahalad, Sampath
Zeft, Andrew S.
Bohnsack, John F.
Mellins, Elizabeth D.
Ilowite, Norman T.
Russo, Ricardo
Len, Claudio
Hilario, Maria Odete E.
Oliveira, Sheila
Yeung, Rae S. M.
Rosenberg, Alan
Wedderburn, Lucy R.
Anton, Jordi
Schwarz, Tobias
Hinks, Anne
Bilginer, Yelda
Park, Jane
Cobb, Joanna
Satorius, Colleen L.
Han, Buhm
Baskin, Elizabeth
Signa, Sara
Duerr, Richard H.
Achkar, J. P.
Kamboh, M. Ilyas
Kaufman, Kenneth M.
Kottyan, Leah C.
Pinto, Dalila
Scherer, Stephen W.
Alarcon-Riquelme, Marta E.
Docampo, Elisa
Estivill, Xavier
Guel, Ahmet
de Bakker, Paul I. W.
Raychaudhuri, Soumya
Langefeld, Carl D.
Thompson, Susan
Zeggini, Eleftheria
Thomson, Wendy
Kastner, Daniel L.
Woo, Patricia
Üst veri
Tüm öğe kaydını gösterÖzet
Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P = 2.8 x 10(-17), odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P = 1.0 x 10(-5), OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed that HLA-DRB1*11 and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P = 2.7 x 10(-16), OR 2.3 (1.9, 2.8)], as was the HLA-DRB1*11-HLA-DQA1*05-HLA-DQB1*03 haplotype [6.4 x 10(-17), OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.